Dr. Madesis Panagiotis
  +30 2311 257 531
  • bg_page-0
  • bg_page-1
  • bg_page-2


Microalgae biomass represents a rich source for discovery. The potential for algae-based ingredients in the industry relies on the manipulation and targeting of ingredients to fit increasingly niche product specifications. Algae are exposed to extreme environment and thus have developed unique mechanism for protection. Furthermore, algae produce for the same reason different metabolites which we need to identify and exploit in a sustainable way for the production of food, drugs and cosmetics.

The AlgaeCeuticals project will take advantage of the native algae strains producing high added value products and through the application of novel omics technologies (genomics, transcriptomics, proteomics, enzymomics and metabolomics) as well as algae culture technologies and production of novel products. AlgaeCeuticals will screen and characterize algae biodiversity, develop and optimize algae culture systems, develop omics resources for algae and also develop downstream processing strategies and also develop novel products. For this reason and in order to achieve its object 4 academic and research centers from Greece (CERTH/INAB; AUA), Spain (CTNC, Centro Tecnológico Nacional de la Conserva y Alimentación) and Italy (FEM) will collaborate for four years with three industrial R&D partners from Greece (Fresh Formula), Spain (Bionos Biotech ND;) and Austria (Ecoduna AG). Through this collaboration the academic partners will work closely with the industrial R&D and form a complementary and highly competitive team that will promote transfer of knowledge and excellence to industrial partners. This will strengthen the industrial competitiveness in the field of food and cosmetics in the process of the design, development, testing of the products proposed by the project.


Project Number: 778263 Funding scheme: H2020-MSCA-RISE-2017 (Marie Skłodowska-Curie Research and Innovation Staff Exchange)